INBIOGEN Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was KRW 927.79 million compared to KRW 1,666.66 million a year ago. Net loss was KRW 7,014.57 million compared to KRW 15,137.02 million a year ago.
For the nine months, sales was KRW 4,311.44 million compared to KRW 4,363.23 million a year ago. Net loss was KRW 134,580.97 million compared to KRW 22,915.66 million a year ago.